Groupama Asset Managment purchased a new position in shares of The Clorox Company (NYSE:CLX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 12,011 shares of the company’s stock, valued at approximately $1,939,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Brooklyn Investment Group lifted its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Continuum Advisory LLC lifted its stake in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Clorox during the 4th quarter valued at $31,000. Asset Planning Inc bought a new stake in Clorox during the 4th quarter worth $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new position in Clorox in the 4th quarter worth about $36,000. 78.53% of the stock is currently owned by institutional investors.
Clorox Stock Down 0.1 %
Clorox stock opened at $147.77 on Thursday. The company has a market capitalization of $18.20 billion, a PE ratio of 40.37, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm’s fifty day moving average is $150.61 and its 200 day moving average is $158.66. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.
Analyst Ratings Changes
Several analysts have recently weighed in on CLX shares. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays decreased their price target on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a research report on Thursday, March 27th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. DA Davidson decreased their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Clorox presently has an average rating of “Hold” and an average target price of $159.00.
Get Our Latest Stock Report on CLX
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- How to Use the MarketBeat Excel Dividend Calculator
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is the Euro STOXX 50 Index?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What Are Some of the Best Large-Cap Stocks to Buy?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.